George D. Hartman

9.8k citations

183 papers · 5.4k indexed · h-index 40

Molecular Biology top 2%
Organic Chemistry top 1%
Cellular and Molecular Neuroscience top 5%
Epidemiology top 5%
Immunology and Allergy top 1%

Co-authors: Mark E. Duggan Wasyl Halczenko Hans E. Huber Craig W. Lindsley Mark T. Bilodeau R. Robinson Deborah Defeo-Jones Melissa S. Egbertson
Topics: Platelet Disorders and Treatments (23 papers)Synthesis and Biological Evaluation (20 papers)Cell Adhesion Molecules Research (19 papers)
Cited by: Immunology and Allergy Organic Chemistry Hepatology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States Belgium Canada

In The Last Decade

George D. Hartman

183 papers receiving 5.2k citations

Peers

Countries citing papers authored by George D. Hartman

Since Specialization

Citations

This map shows the geographic impact of George D. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George D. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George D. Hartman more than expected).

Fields of papers citing papers by George D. Hartman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George D. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George D. Hartman. The network helps show where George D. Hartman may publish in the future.

Co-authorship network of co-authors of George D. Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of George D. Hartman. A scholar is included among the top collaborators of George D. Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George D. Hartman. George D. Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection 2019 ·Gastroenterology ·Man‐Fung Yuen,Edward Gane,Dong Joon Kim,Frank Weilert,Henry Lik‐Yuen Chan,Jacob Lalezari,Seong Gyu Hwang,Tuan Nguyen,Osvaldo Flores,George D. Hartman,(unknown),Oliver Lenz,Thomas N. Kakuda,Willem Talloen,Christian Schwabe,Klaus Klumpp,Nathaniel Brown	117
2	Benzimidazole CB2 agonists: Design, synthesis and SAR 2013 ·Bioorganic & Medicinal Chemistry Letters ·Kausik K. Nanda,Darrell A. Henze,Kimberly Della Penna,Reshma R. Desai,Michael Leitl,Wei Lemaire,Rebecca B. White,Suzie Yeh,Janine N. Brouillette,George D. Hartman,Mark T. Bilodeau,B. Wesley Trotter	22
3	Pyridyl aminothiazoles as potent Chk1 inhibitors: Optimization of cellular activity 2012 ·Bioorganic & Medicinal Chemistry Letters ·Vadim Dudkin,Cheng Wang,Kenneth L. Arrington,Mark E. Fraley,George D. Hartman,Steven M. Stirdivant,Robert Drakas,Keith Rickert,Eileen S. Walsh,Kelly Hamilton,Carolyn A. Buser,James C.H. Hardwick,Weikang Tao,Stephen C. Beck,Xianzhi Mao,Robert B. Lobell,Laura Sepp‐Lorenzino	6
4	Discovery of selective glucocorticoid receptor modulator MK-5932 2011 ·Bioorganic & Medicinal Chemistry ·Christopher J. Bungard,George D. Hartman,(unknown),James J. Perkins,Chang Bai,Philip E. Brandish,(unknown),James C. Hershey,Azriel Schmidt,Yulin Fang,(unknown),Tom Rushmore,Charles D. Thompson,Robert Meißner	16
5	Synthesis and evaluation of a new series of Neuropeptide S receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey Y. Melamed,(unknown),Nathan R. Kett,Anthony L. Gotter,Victor N. Uebele,Duane R. Reiss,Cindra Condra,Christine Fandozzi,Laura S. Lubbers,Blake A. Rowe,Georgia B. McGaughey,Martin Hénault,Rino Stocco,John J. Renger,George D. Hartman,Mark T. Bilodeau,B. Wesley Trotter	21
6	N-Heterocyclic derived M1 positive allosteric modulators 2010 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,(unknown),(unknown),William J. Ray,Lei Ma,Marion Wittmann,Lone Veng,Matthew A. Seager,(unknown),Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	25
7	Fused heterocyclic M1 positive allosteric modulators 2010 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,(unknown),William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth A. Koeplinger,Charles D. Thompson,George D. Hartman,Mark T. Bilodeau	14
8	High concentration electrophysiology-based fragment screen: Discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg,Zhijian Zhao,(unknown),Scott T. Harrison,John M. Sanders,Matthew J. Cato,Aneta Jovanovska,(unknown),Sean P. Cook,Darrell A. Henze,Stefanie A. Kane,George D. Hartman,James C. Barrow	17
9	Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao,William Leister,Julie A. O’Brien,Wei Lemaire,David L. Williams,Marlene A. Jacobson,Cyrille Sur,Gene G. Kinney,D. J. PETTIBONE,Philip R. Tiller,Sheri Smith,George D. Hartman,Craig W. Lindsley,S. E. Wolkenberg	16
10	Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity 2007 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao,R. Robinson,Stanley F. Barnett,Deborah Defeo-Jones,Raymond E. Jones,George D. Hartman,Hans E. Huber,Mark E. Duggan,Craig W. Lindsley	38
11	Rapid assembly of diverse and potent allosteric Akt inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Zhicai Wu,R. Robinson,Sheng Fu,Stanley F. Barnett,Deborah Defeo-Jones,Raymond E. Jones,Astrid M. Kral,Hans E. Huber,Nancy E. Kohl,George D. Hartman,Mark T. Bilodeau	41
12	Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides 2006 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao,Julie A. O’Brien,Wei Lemaire,David L. Williams,Marlene A. Jacobson,Cyrille Sur,D. J. PETTIBONE,Philip R. Tiller,Sheri Smith,George D. Hartman,S. E. Wolkenberg,Craig W. Lindsley	12
13	Discovery of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP 2005 ·Cancer Research ·Mark E. Fraley,(unknown),(unknown),(unknown),George D. Hartman,(unknown),Carolyn A. Buser,Weikang Tao,Hans E. Huber,Nancy E. Kohl	1
14	Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao,William Leister,R. Robinson,Stanley F. Barnett,Deborah Defeo-Jones,Raymond E. Jones,George D. Hartman,Joel R. Huff,Hans E. Huber,Mark E. Duggan,Craig W. Lindsley	125
15	Kinase insert domain-containing receptor kinase inhibitors as anti-angiogenic agents 2002 ·Expert Opinion on Investigational Drugs ·George D. Hartman,Mark E. Fraley,Mark T. Bilodeau	39
16	Oxo-piperazine Derivatives of N-Arylpiperazinones as Inhibitors of Farnesyltransferase 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jeffrey M. Bergman,Donna Wei,C. Blair Zartman,Joseph P. Davide,Ian Greenberg,Dongming Liu,Timothy J. O’Neill,W. Wayt Gibbs,Kenneth S. Koblan,Nancy E. Kohl,Robert B. Lobell,I‐Wu Chen,Debra A. McLoughlin,Timothy Olah,Samuel Graham,George D. Hartman,Theresa M. Williams	22
17	Flow cytometric measurement of kinetic and equilibrium binding parameters of arginine-glycine-aspartic acid ligands in binding to glycoprotein IIb/IIIa on platelets 1997 ·Cytometry ·Bohumil Bednář,Michael E. Cunningham,(unknown),Melissa S. Egbertson,(unknown),Rodney A. Bednar,George D. Hartman,Robert J. Gould	36
18	Non-Peptide Fibrinogen Receptor Antagonists. 2. Optimization of a Tyrosine Template as a Mimic for Arg-Gly-Asp 1994 ·Journal of Medicinal Chemistry ·Melissa S. Egbertson,(unknown),(unknown),R J Gould,Wasyl Halczenko,George D. Hartman,William L. Laswell,Joseph J. Lynch,Robert J. Lynch	147
19	3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogs 1992 ·Journal of Medicinal Chemistry ·George D. Hartman,Wasyl Halczenko,(unknown),(unknown),Robert L. Smith,Steven M. Pitzenberger,Susan L. Fitzpatrick,Alfred W. Alberts,R. Bostedor	8
20	Motion Detection by Correlation and Voting 1990 ·MPG.PuRe (Max Planck Society) ·S. Bohrer,HH Bülthoff,(unknown),(unknown),George D. Hartman,G. Hauske	3

About George D. Hartman

George D. Hartman is a scholar working on Immunology and Allergy, Hematology and Organic Chemistry, having authored 183 papers that have together received 5.4k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (23 papers), Synthesis and Biological Evaluation (20 papers) and Cell Adhesion Molecules Research (19 papers). The work is most often cited by research in Immunology and Allergy (529 citations), Organic Chemistry (1.7k citations) and Hepatology (466 citations). George D. Hartman has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Mark E. Duggan, Wasyl Halczenko, Hans E. Huber, Craig W. Lindsley, Mark T. Bilodeau, R. Robinson, Deborah Defeo-Jones, Melissa S. Egbertson, Zhijian Zhao and Stanley F. Barnett. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact